Press release
Ovarian Cancer Drugs Market - Global Demand Analysis & Opportunity Outlook 2025
Download PDF Brochure For More Insights@ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=34061
According to American Cancer Society estimates, risk of any woman acquiring ovarian cancer in her lifetime is 1 in 75, while her chance of death due to ovarian cancer is 1 in 100. Ovarian cancer is more prevalent among elderly women, making women over 55 a high-risk population. Women in this age group have the lowest survival rate as well. Surgical procedures are employed for the treatment of both early and advanced stages of ovarian cancer. According to American Cancer Society estimates, about 22,440 women are expected to be diagnosed with ovarian cancer in the U.S., while about 14,080 women deaths would be attributed to ovarian cancer in 2017.
Ovarian cancer and its rising incidence rate is a growing concern worldwide. Market players that are currently engaged in the development of drugs and chemotherapies for management of ovarian cancer. The global ovarian cancer drugs market is expected to be driven by large number of therapeutics in developmental stage and competition among market players in terms of efficacy and cost of therapies. The patent expiry of several leading drugs could also potentially impact this market by encouraging the entry of new players. These changing dynamics will impact the ovarian cancer market during the forecast period. The global ovarian cancer drugs market holds immense potential and is anticipated to grow rapidly.
Continuous research and development to provide efficient therapeutic intervention for a host of diseases boosts the growth of the ovarian cancer drugs market. Several ovarian cancer drugs are in clinical phase and expected to drive the market in the near future. For instance, Merck, Pfizer, and Syndax Pharmaceuticals, Inc. have signed an exclusive agreement to study two investigational agents or drugs for treatment of ovarian cancer. This study includes the drugs Avelumab and entinostat evaluated for efficacy as combination therapy for ovarian cancer.
Obtain Report Details @ https://www.transparencymarketresearch.com/ovarian-cancer-drugs-market.html
The global ovarian cancer drugs market can be segmented based on tumor type, drug class, distribution channel, and region. In terms of tumor type, the market can be classified into epithelial ovarian cancer, ovarian low malignant potential tumor, germ cell tumor, and sex cord-stromal tumor. Based on drug class, the global ovarian cancer drugs market can be categorized into alkylating agents, mitotic inhibitors, antirheumatics, antipsoriatics, VEGF/VEGFR inhibitors, PARP inhibitors, antineoplastics, and others. In terms of distribution channel, the market can be divided into hospital pharmacies, drug stores, online pharmacies, and others. In terms of region, the global ovarian cancer drugs market can be segmented into Asia Pacific, Europe, Middle East & Africa, North America, and Latin America. Major players in the global ovarian cancer drugs market are Allergan plc, Pfizer, Inc., Merck KGaA, AstraZeneca, F. Hoffmann-La Roche AG, Johnson & Johnson, Syndax Pharmaceuticals, Inc., Clovis Oncology, and others.
About TMR
Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.
Contact TMR
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: https://www.transparencymarketresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Ovarian Cancer Drugs Market - Global Demand Analysis & Opportunity Outlook 2025 here
News-ID: 1112904 • Views: …
More Releases from Transparency Market Research
Global Bakery Processing Equipment Market to Reach US$ 22.5 Billion by 2035 Repo …
The bakery industry is undergoing a major technological and structural transformation. As global consumers increasingly crave convenient, high-quality, and specialty baked products, the Bakery Processing Equipment Market is witnessing significant expansion. Valued at US$ 14.3 billion in 2024, the market is projected to grow at a compound annual growth rate (CAGR) of 7.9% from 2025 to 2035, ultimately reaching US$ 22.5 billion by the end of the forecast period.
The rise…
Bioinformatics Market to Reach USD 86.9 Billion by 2035 | Driven by AI Integrati …
The global bioinformatics market continues to gain substantial momentum as the fusion of biological science and data analytics redefines healthcare, biotechnology, and pharmaceutical research. According to recent industry data, the market was valued at US$ 22.2 billion in 2024 and is anticipated to grow at an impressive CAGR of 13.3% from 2025 to 2035, reaching US$ 86.9 billion by 2035. The acceleration in adoption of next-generation sequencing (NGS), increasing use…
Global Hydrogen-Based Renewable Energy Market to Hit US$ 34.9 Billion by 2035 | …
According to the latest industry analysis, the global hydrogen-based renewable energy market is entering a transformative growth phase. Valued at US$ 1.8 billion in 2024, the market is expected to expand at an exceptional CAGR of 32.5% between 2025 and 2035, reaching approximately US$ 34.9 billion by 2035. This growth trajectory reflects the critical role hydrogen will play in global energy transition strategies, with governments and industries accelerating adoption to…
Global Rose Water Market Set to Reach US$ 973 Million by 2035, Reports by Transp …
The global rose water market is poised for significant expansion, underpinned by the rising global inclination toward clean-label beauty, wellness-focused lifestyles, and botanical ingredients. According to the latest research, the industry was valued at US$ 453.0 million in 2024 and is projected to grow at a CAGR of 7.2% from 2025 to 2035, reaching US$ 973.0 million by 2035.
Rose water - a natural aromatic liquid derived through the steam distillation…
More Releases for Ovarian
Ovarian Cancer Diagnostics Market Size: 2033 Statistics
The Ovarian Cancer Diagnostics market is expected to grow from an estimated USD 4814.5 million in 2024 to USD 7795.1 million in 2033, at a CAGR of 5.50%.
The ovarian cancer diagnostics market plays a critical role in the early detection and management of ovarian cancer, one of the most common and lethal gynecological cancers worldwide. Ovarian cancer is often diagnosed at an advanced stage due to the lack of noticeable…
Ovarian Cancer Market Size, Future Trends
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- The global Ovarian Cancer Market is expected to record a CAGR of XX.X% from 2024 to 2031 In 2024, the market size is projected to reach a valuation of USD XX.X Billion. By 2031 the valuation is anticipated to reach USD XX.X Billion.
The impact of manufacturers on the market is significant across various industries, influencing supply chains, consumer choices, and economic growth. Manufacturers are key players in…
Polycystic Ovarian Syndrome Treatment Market Report
The findings reviewed by GME stated that the Global Polycystic Ovarian Syndrome Treatment Market will expand with a CAGR value of 5.2 percent from 2021 to 2026. The rising incidence of PCOS increased understanding among a group of patients, and the growing acceptance of standard treatment boosts the PCOS treatment industry growth over the projected timeframe. Furthermore, the research and development of PCOS are predicted to aid in market growth.
Browse…
How deadly is Ovarian Cancer?
Ovarian Drugs and Treatment Market describes its growth, size, share, Forecast and trends to 2025
Ovarian cancer is a cancer that forms in or on an ovary. It results in abnormal cells that have the ability to invade or spread to other parts of the body.
The global Ovarian Cancer Treatment Drugs market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025,…
Polycystic Ovarian Syndrome Treatment Market - Regional Analysis
The organic and inorganic strategies by the market players will boost the polycystic ovarian syndrome treatment market. For instance, in 2016, Millendo Therapeutics, Inc., a biopharmaceutical company, entered into an exclusive license agreement with AstraZeneca for the development and commercialization of phase II entered AZD4901, a candidate product for the treatment of polycystic ovarian syndrome. Moreover, in 2017, Astellas Pharma Inc. completed its acquisition of Ogeda SA (formerly Euroscreen S.A.).…
Ovarian Cancer - Heat Map and Analysis
ReportsWorldwide has announced the addition of a new report title Ovarian Cancer - Heat Map and Analysis to its growing collection of premium market research reports.
Ovarian Cancer (OC) is the fifth most common malignancy diagnosed in women, and the most common gynecological cancer, with an estimated 225,000 new cases diagnosed globally in 2008. Rates are particularly high in developed countries, and especially in Northern Europe. However, substantial improvements in…
